Kefir peptides show promise for kidney health
NCT ID NCT07260292
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether taking kefir peptides for three months could help people with stage 3 or 4 chronic kidney disease. Researchers measured kidney function, protein in urine, and signs of inflammation. The goal was to see if this supplement could support disease control, not cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 3 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jen-Ai Hospital
Taichung, 412, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could predict who faces rapid kidney decline in diabetes
- AI therapy coach aims to ease distress in seriously ill seniors
- Zapping kidney nerves: a new hope for stubborn high blood pressure?
- Thousands of kidney patients tracked to unlock better disease management
- Teen diabetes study seeks to uncover hidden triggers of kidney damage
- New study: can a smart glucose monitor help diabetics with kidney problems?